Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Nuo Therapeutics, Inc/ SCHEDULE 13D/A

SEC Filing · SCHEDULE 13D/A

Nuo Therapeutics, Inc

AURXOTCEQUITYCurrent

SEC Filing

Filed Jun 3, 2026Accepted Jun 3, 2026, 11:04 AM EDTCIK 1091596Accession 0001674752-26-000002
View company →Permanent SEC source ↗
Share

Company context

Current securities

AURXOTC · EQUITY · Current

Recent company filings

  1. Results of Operations and Financial ConditionAug 17, 2026
  2. 10-Q filingAug 14, 2026
  3. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity SecuritiesJun 3, 2026
  4. Results of Operations and Financial ConditionMay 14, 2026
  5. 10-Q filingMay 14, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗